763 related articles for article (PubMed ID: 33761582)
41. The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses.
Muhar BK; Nehira J; Malhotra A; Kotchoni SO
J Pharm Pract; 2023 Aug; 36(4):953-966. PubMed ID: 35723017
[TBL] [Abstract][Full Text] [Related]
42. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis?
Tatar M; Shoorekchali JM; Faraji MR; Wilson FA
J Glob Health; 2021 Jul; 11():03086. PubMed ID: 34221356
[No Abstract] [Full Text] [Related]
43. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Hogan MJ; Pardi N
Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
[TBL] [Abstract][Full Text] [Related]
44. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
John TJ; Dharmapalan D
Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
[TBL] [Abstract][Full Text] [Related]
45. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.
Zhang Z; Shen Q; Chang H
Front Immunol; 2022; 13():843928. PubMed ID: 35572592
[TBL] [Abstract][Full Text] [Related]
46. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer.
Chen Y; Cheng L; Lian R; Song Z; Tian J
Biosci Trends; 2021 May; 15(2):64-73. PubMed ID: 33746182
[TBL] [Abstract][Full Text] [Related]
47. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
Jhaveri R
Clin Ther; 2021 Mar; 43(3):549-556. PubMed ID: 33579547
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in the vaccine development for the prophylaxis of SARS Covid-19.
Kumar V; Kumar S; Sharma PC
Int Immunopharmacol; 2022 Oct; 111():109175. PubMed ID: 35994853
[TBL] [Abstract][Full Text] [Related]
49. Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review.
Saied AA; Metwally AA; Madkhali NAB; Haque S; Dhama K
Front Public Health; 2021; 9():696082. PubMed ID: 34485226
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed.
Jimenez M; Campillo NE; Canelles M
Curr Med Chem; 2021; 28(20):3964-3979. PubMed ID: 33109026
[TBL] [Abstract][Full Text] [Related]
51. The role of vaccines in the COVID-19 pandemic: what have we learned?
Krammer F
Semin Immunopathol; 2024 Jan; 45(4-6):451-468. PubMed ID: 37436465
[TBL] [Abstract][Full Text] [Related]
52. Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy.
Parums DV
Med Sci Monit; 2021 Sep; 27():e934625. PubMed ID: 34483336
[TBL] [Abstract][Full Text] [Related]
53. Biological composition, efficacy and primary efficacy endpoint of SARS-CoV-2 vaccines: A special communication.
Ishaque I; Muhib M; Khalid Jamil OB
J Pak Med Assoc; 2022 Nov; 72(11):2264-2269. PubMed ID: 37013299
[TBL] [Abstract][Full Text] [Related]
54. Canada is no global health leader on COVID-19 vaccine equity.
Houston AR; Murthy S
Lancet; 2021 May; 397(10287):1803. PubMed ID: 33992135
[No Abstract] [Full Text] [Related]
55. COVID-19 vaccines: rapid development, implications, challenges and future prospects.
Kashte S; Gulbake A; El-Amin Iii SF; Gupta A
Hum Cell; 2021 May; 34(3):711-733. PubMed ID: 33677814
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 and vaccination: myths vs science.
Chavda VP; Chen Y; Dave J; Chen ZS; Chauhan SC; Yallapu MM; Uversky VN; Bezbaruah R; Patel S; Apostolopoulos V
Expert Rev Vaccines; 2022 Nov; 21(11):1603-1620. PubMed ID: 35980281
[TBL] [Abstract][Full Text] [Related]
57. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.
Bhatta M; Nandi S; Dutta S; Saha MK
Hum Vaccin Immunother; 2022 Dec; 18(1):1865774. PubMed ID: 33545014
[TBL] [Abstract][Full Text] [Related]
58. A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review.
Talukder A; Kalita C; Neog N; Goswami C; Sarma MK; Hazarika I
Z Naturforsch C J Biosci; 2022 Jul; 77(7-8):351-362. PubMed ID: 35245422
[TBL] [Abstract][Full Text] [Related]
59. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
Lagman JDN
J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
[TBL] [Abstract][Full Text] [Related]
60. Landscape and progress of global COVID-19 vaccine development.
Huang HY; Wang SH; Tang Y; Sheng W; Zuo CJ; Wu DW; Fang H; Du Q; Li N
Hum Vaccin Immunother; 2021 Oct; 17(10):3276-3280. PubMed ID: 34254894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
